October 23, 2026 03:31 am (IST)

Make this your homepage

Health

Tiger Shroff, not Salman Khan, was the main target, probe reveals shocking details | Dammam airport attack: Indian killed, two compatriots injured as Saudi Arabia faces fresh strikes | ‘Among others’: Macron takes swipe at Trump over France unrest, calls foreign leaders’ remarks ‘stupid’ | ‘Specific threat-related inputs’: Delhi Police blocks Diljit Dosanjh’s Delhi concert | ‘Barbaad kare alfaz mere’: Ranbir Kapoor apologises for Dussehra gaffe in Kolkata | Delhi court releases CJP's Saurav Das and Ashutosh Ranka after 7 days in custody | ‘We are seeing what is happening outside our country’: Delhi HC judge’s remark as CJP leaders Saurav Das and Ashutosh Ranka withdraw custody plea | Salman Khan was the original target? Tiger Shroff firing probe reveals shocking twist | ‘UN experts are an oxymoron’: Marco Rubio takes swipe at UN, refuses to comment on India's protests | ‘US ties with no country come at India's expense’: Marco Rubio addresses concerns over Pakistan, China

Covaxin

Image tweeted by @IndianEmbassyTR

Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech

IBNS | @indiablooms | Jul 03, 2021, at 06:54 pm

New Delhi/IBNS: Hyderabad-based biotechnology company Bharat Biotech has claimed its anti-COVID-19 vaccine, Covaxin, is 77.8% effective against the deadly virus.

Bharat Biotech made the claim in the phase three clinical trial data of the vaccine.

The company has further claimed Covaxin is 93.4% effective against severe symptomatic COVID-19 cases, 63.6% against asymptomatic COVID-19 cases and 65.2% against the Delta variant.

COVAXIN® Proven SAFE in India's Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published on https://t.co/JJh9n3aB6V pic.twitter.com/AhnEg56vFN
— BharatBiotech (@BharatBiotech) July 2, 2021

Bharat Biotech co-founder Suchitra Ella tweeted, "We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic."

We are proud to put India on the global map with scientific conviction,competence & commitment. #Covaxin scores #10 world class publications endorsing Innovation, clinical research,data,safety, efficacy. Thanq collaborators & Positive BB teamwork enduring a pandemic 😇👏🏼👍🏼💉🇮🇳🙏🏼 https://t.co/c5f43WOAbQ
— suchitra ella (@SuchitraElla) July 2, 2021

At present four anti-COVID-19 vaccines including Covaxin have been permitted by the central government to be used in the vaccination drive.

Apart from Covaxin, three other vaccines are AstraZeneca's Indian version Covishield, Russia's Sputnik and US-made Moderna.

#COVID19 #BharatBiotech #Covaxin #DeltaVariant

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.